JOIN our innovation week | 6 - 10 december 2021

Take a ride on the Evotec "Data-driven R&D Autobahn to Cures" 

5 virtual sessions over 5 days discussing:

  • How Evotec is using data and science across treatment modalities to accelerate innovation in the area of precision medicine to deliver enhanced speed, lower cost, and predictive efficacy

  • Our efforts in AI/ML in the design and development of both small molecules and antibodies, the importance of  biomarker development, targeting RNA, and our approaches to target validation

The sessions take place each day from Monday 6th to Friday 10th December 2021

@ 4 pm GMT | 5 pm CET | 11 am EST | 8 am PST.

Each session will take c. 45 min including a Q&A session.


Click on the buttons in the right column to reserve your seat. 

Please note you will need to register for each session individually.

Program

Day 1 | Monday, 6 December
4 pm GMT | 5 pm CET |

11 am EST | 8 am PST
Drug discovery in the Evotec multiverse: Knowledge-driven integrated R&D

Adam Davenport | EVP, Head of Global Molecular Discovery
Tim James | VP, Head of Data Science
Christophe Boldron | VP, Head of Molecular Architects

Session complete.

Day 2 | Tuesday, 7 December

4 pm GMT | 5 pm CET |

11 am EST | 8 am PST

 The importance of precision medicine: How biomarkers optimize translation from bench to bedside and back

Elizabeth van der Kam | SVP, Translational Biomarkers
Christoph Schaab | SVP, Head of Proteomics and Metabolomics

Session complete.

Day 3 | Wednesday, 8 December

4 pm GMT | 5 pm CET |

11 am EST | 8 am PST

 The early bird catches the helix: Expanding the druggable target space to RNA

Steffen Grimm | Group Leader, Hit ID and Biophysics
Hilary Brooks | Senior Research Scientist, In Vitro Pharmacology

Session complete.

Day 4 | Thursday, 9 December

4 pm GMT | 5 pm CET |

11 am EST | 8 am PST

 Do firefighters cause fires? Establishing real disease associations through target validation

Hauke Cornils | VP, Early Discovery

Ken Young | Group Leader, In Vitro Pharmacology

 Session complete.

Day 5 | Friday, 10 December

4 pm GMT | 5 pm CET |

11 am EST | 8 am PST



 

 Translate your idea into product: AI-driven antibody discovery at Evotec

Barbara Bachler-Konetzki | Group Leader, In Vitro Pharmacology
Randal Ketchem | SVP, Discovery and Molecular Design
Maria Pilla | EVP, Global Head of Preclinical Development

 Session complete.

All sessions will be moderated by Christophe Muller, EVP, Global Head of Business Development and

Ryan Brady, EVP, Head of Business Development